{
    "Allocation": "Randomized",
    "CompleteTime": 60,
    "DesignModel": "Parallel Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "ct1812: 300 mg 6 months(once daily) , ",
                "ArmGroupLabel": "Active Treatment- CT1812 100 mg",
                "ArmGroupType": "Active Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "100 mg",
                        "DrugName": "ct1812",
                        "Duration": "6 months(once daily)",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: CT1812"
                    ]
                }
            },
            {
                "ArmGroupDescription": "ct1812: 300 mg 6 months(once daily) , ",
                "ArmGroupLabel": "Active Treatment- CT1812 300 mg",
                "ArmGroupType": "Active Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "300 mg",
                        "DrugName": "ct1812",
                        "Duration": "6 months(once daily)",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: CT1812"
                    ]
                }
            },
            {
                "ArmGroupDescription": "placebo:  182 days , ",
                "ArmGroupLabel": "Placebo Comparator - Placebo",
                "ArmGroupType": "Placebo Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "placebo",
                        "Duration": "182 days",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Placebo"
                    ]
                }
            }
        ]
    },
    "Enrollment": "144",
    "InterventionName": "ct1812, Placebo",
    "Masking": "Quadruple",
    "NCTID": "NCT03507790",
    "Objective": "A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.",
    "OfficialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.",
    "PopulationBox": {
        "Condition": "Mild to Moderate Alzheimer's Disease",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "85 Years",
        "MinAge": "50 Years",
        "Participant": "144"
    },
    "PopulationRatio": "1.0 : 1.0 : 1.0",
    "Title": "A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.",
    "WashoutPeriod": ""
}